DUALITY ADVISERS, LP – Alnylam Pharmaceuticals, Inc. Transaction History
DUALITY ADVISERS, LP portfolio value:
$3.38M
portfolio value
DUALITY ADVISERS, LP quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +363.47% | 13.27K shares | 2.85M | $200.16 | 16.92K |
| Q2 2022 | share | Decrease | -33.25% | -1.81K shares | -360K | $145.85 | 3.65K |
| Q1 2022 | share | Decrease | -55.06% | -6.70K shares | -1.17M | $163.29 | 5.47K |
| Q4 2021 | share | Decrease | -27.56% | -4.63K shares | -1.10M | $171.03 | 12.17K |
| Q3 2021 | share | Increase | 0.00% | 16.80K shares | 3.17M | $188.81 | 16.80K |
| Q2 2021 | share | Decrease | -100.00% | -12.03K shares | -1.7M | $169.52 | 0 |
| Q1 2021 | share | Decrease | -29.27% | -4.98K shares | -512K | $141.19 | 12.03K |
| Q4 2020 | share | Increase | 0.00% | 17.02K shares | 2.21M | $129.97 | 17.02K |